Journal of Stem Cells and Genetics Open Access is an international peer reviewed journal for scientists dealing with stem cells, diseases and relevant areas. It also includes basic and translational laboratory research and clinical applications in developing stem cell therapeutics. We will consider studies from any model system that provides insights into stem cell biology, and we encourage submissions on human stem cells.
Scientific Synergy Journal publishes original articles, editorials letters to the editor, review articles, case reports, Opinion, Mini review and Editorial articles, describing original research in the fields below
Classification of Journal
Cancer stem cells
Embryonic stem cells
Embryonic germ cells
Mesenchymal stem cells
Hematopoietic stem cell
Induced pluripotent stem cells
Neural stem cell
Inner cell mass (ICM)
Submit your Manuscript: email@example.com
Manuscripts should be submitted by one of the authors of the manuscript by filling submit manuscript form or by sending through e-mail. Regardless of the source of the word-processing tool, only electronic PDF (.pdf) or Word (.doc, .Docx, .rtf) files can be submitted through submit manuscript form. There is no page limit. Only online submissions are accepted to facilitate rapid publication and minimize administrative costs. Submissions by anyone other than one of the authors will not be accepted. The submitting author takes responsibility for the paper during submission and peer review. If for some technical reason submission through the SM is not possible, the author can contact firstname.lastname@example.org for support.
Terms of Submission:
Papers must be submitted on the understanding that they have not been published elsewhere and are not currently under consideration by another journal published by Eagle Publishing Group or any other publisher. The submitting author is responsible for ensuring that the article’s publication has been approved by all the other co-authors. It is also the author’s responsibility to ensure that the articles emanating from a particular institution are submitted with the approval of the necessary institution. Only an acknowledgment from the editorial office officially establishes the date of receipt. Further correspondence and proofs will be sent to the author(s) before publication unless otherwise indicated. It is a condition of submission of a paper that the authors permit editing of the paper for readability. All enquiries concerning the publication of accepted papers should be addressed to email@example.com
All manuscripts are subject to peer review and are expected to meet standards of academic excellence. Submissions will be considered by an editor and “if not rejected right away” by peer-reviewers, whose identities will remain anonymous to the authors.
Units of Measurement:
Units of measurement should be presented simply and concisely using System International (SI) units.
Title and Authorship Information:
The following information should be included:
Full author names
Full institutional mailing addresses
The manuscript should contain an abstract. It should contain brief introduction of research and citation-free. Abstract should not exceed 250 words.
This section should be succinct, with no subheadings.
Materials and Methods:
This part should contain sufficient detail so that all procedures can be repeated. It can be divided into subsections if several methods are described.
Results and Discussion:
This section may each be divided by subheadings or may be combined.
This should clearly explain the main conclusions of the work highlighting its importance and relevance.
All acknowledgments (if any) should be included at the very end of the paper before the references and may include supporting grants, presentations, and so forth.
Authors are responsible for ensuring that the information in each reference is complete and accurate. All references must be numbered consecutively and citations of references in the text should be identified using numbers in square brackets (e.g., “as discussed by Smith ”; “as discussed elsewhere [9, 10]”). All references should be cited within the text; otherwise, these references will be automatically removed.
Preparation of Figures:
Upon submission of an article, authors are supposed to include all figures and tables in the PDF file of the manuscript. Figures and tables should not be submitted in separate files. If the article is accepted, authors will be asked to provide the source files of the figures. Each figure should be supplied in a separate electronic file. All figures should be cited in the paper in a consecutive order. Figures should be supplied in either vector art formats (Illustrator, EPS, WMF, FreeHand, CorelDraw, PowerPoint, Excel, etc.) or bitmap formats (Photoshop, TIFF, GIF, JPEG, etc.). Bitmap images should be of 300 dpi resolution at least, unless the resolution is intentionally set to a lower level for scientific reasons. If a bitmap image has labels, the image and labels should be embedded in separate layers.
Preparation of Tables:
Tables should be cited consecutively in the text. Every table must have a descriptive title and if numerical measurements are given, the units should be included in the column heading. Vertical rules should not be used.
Corrected proofs must be returned to the publisher within 2-3 days of receipt. The publisher will do everything possible to ensure prompt publication. It will therefore be appreciated if the manuscripts and figures conform from the outset to the style of the journal.
Howard R Moskowitz
Mind Genomics Advisors, USABiography | Research Interest
Howard R. Moskowitz founded Mind Genomics Associates in 2014, to promote the development and use of the new science of Mind Genomics. The science creates an archival and action-oriented database for knowledge about how people think about the aspects of their daily life. The science is used in business to drive 1:1 sales and marketing, and in social research to understand what is important, and what should be communicated to citizens of a country for socially relevant issues.
Moskowitz is also chairman of Mind Genomics Advisors, a consulting firm which provides innovative, customized predictive analytics for a variety of organizations, using the Mind Genomics platform.
Moskowitz is a well-known experimental psychologist in the field of psychophysics and creator of world-class market research technology. In 1969, Dr. Moskowitz earned a Ph.D. in Experimental Psychology from Harvard University. He graduated Phi Beta Kappa from Queens College (CUNY) with degrees in mathematics and psychology.
Howard Moskowitz received awards for his innovative contributions to the field of marketing research. He received the “2012 Edison Award for Innovation” (Bronze Award - Applied Technology/Research Tools category) for the creation of Mind Genomics®, the aforementioned internationally-recognized science using experimental design and predictive analytics to uncover individual human preferences for products, services, ideas and social issues. Dr. Moskowitz has also received: the “2010 Walston Chubb Award for Innovation” across all sciences from Sigma Xi - The Scientific Research Society; the Advertising Research Foundation’s first “Research Innovation Award” in 2006; the 2004 “David R. Peryam Award" from ASTM for outstanding contributions in basic and applied sensory science, and ESOMAR (European Society of Market Research) Awards in 2001, 2003, 2004 & 2006 for research innovation.
In 2005 Dr. Moskowitz received the American Marketing Association’s 2005 “Charles Coolidge Parlin Marketing Research Award.” The AMA “Parlin Marketing Research” award is considered the “Nobel Prize” of market research and has been given to pioneers in the field of marketing including: Arthur Nielsen, George Gallup, Michael Porter, David Ogilvy and Philip Kotler. In 2004, Dr. Moskowitz was elected an Institute of Food Technologist Fellow and in 2006 he was inducted into the Hall of Fame of New York’s Market Research Council.
Dr. Howard Moskowitz is also a distinguished author, speaker, and mentor to students world-wide. He has written/edited 26 books and over 400 scientific publications on the mind of the consumer. The books span a wide range of topics, ranging from business to mentoring students. The books include: “Selling Blue Elephants: How to make great products that people want before they even know they want them” (Pearson/Wharton School Publishing, 2007) published in 14 languages/editions, Packaging Research in New Food Product Development (Wiley-Blackwell, 2009), and Rule Developing Experimentation: A Systematic Approach to Understand & Engineer the Consumer Mind (Bentham eBooks, 2012). In 2010, Dr. Moskowitz wrote YOU! What you MUST know to start your career as a professional. Recently Dr. Moskowitz completed a new set of 19 books on Mind Genomics, with the intent to publish these as e-books, affordable to students and professionals alike.
His research interest is Mind Genomics, experimental psychologist, Food Product Development and Rule Developing Experimentation
University of Maryland, USABiography | Research Interest
Vikas Saxena committed for scientific endeavors towards ameliorating infectious diseases amongst animals and humans by using immunological approaches. During his master’s in veterinary anatomy he analyzed anatomical conformities of the salivary glands of goat by using light microscopy (Indian Journal of Animal Sciences, 2007). During my PhD dissertation research under the mentorship of Dr. Michael Lai, he analyze role of host cellular factors, by using several biochemical and molecular virology related tools. He identified that annexin A2 serve as a scaffold for viral non-structural proteins on lipid raft region, where the HCV replication complex is assembled (Journal of Virology, 2012). Further, using my expertise in co focal and electron microscopy and by developing an in-vitro culture model for CVRNA replication we elucidated mechanism of HCV release via exosome (Plos One, 2014). During my postdoctoral training with Dr. Christopher Walker he helped in a study to analyze escape mutations acquired by cell culture-derived HCV during persistent infection in a chimpanzee and thus highlighted the possible pattern of molecular evolution of a poorly fit virus (Journal of Virology, 2014). Besides, he have also developed rhesus macaque model to study T cell mediated control of hepatitis E virus (HEV) infection. By using IFN-γ spot forming assay (ELISPOT) and flow cytometry based techniques, we identified HEV specific CD8+ T cells exerting control over persistent viral infection. The exact mechanism underlying viral persistence is under evaluation. Further, in the laboratory of Dr Emma Teixeiro working as a Postdoctoral Fellow, he explored mechanism involved in the development of memory CD8 T cells. By using Listeria monocytogenes and transgenic mice we elucidated importance of T cell receptor(TCR) governed signaling mechanism involving NFkB-Pim-1 axis, which is important for the fitness of memory CD8T cells (PNAS, 2017). Also, he elucidated mechanism of TCR and pro-inflammatory cytokine receptor signaling cooperation, (Journal of Immunology, 2016). Presently,he is working towards understanding lymphotoxin mediated regula
Molecular Virology, Immune Response, Replication and pathogenesis of hepatotropic viruses, CD4, CD8 and regulatory T cells, Cancer Vaccine, Immunology, and solid organ transplantation
University of Campania, ItalyBiography | Research Interest
Dario Siniscalco is biochemist for the Department of Experimental Medicine of the University of Campania, Italy. He graduated in Chemistry from the University of Naples “Federico II” in 2000 and received his Ph.D. in Pharmacological Sciences from Second University of Naples in 2004. He completed his neuropathology fellowship at University of Alabama at Birmingham, USA before joining the Second University of Naples staff in 2006. He is registered member of the following scientific societies: Order of the Chemists of Campania, National Council for Chemistry, Stem Cell Research Italy, International Association of Neurorestoratology, European Association for Chemical and Molecular Sciences, Italian Pharmacological Society, Cell Death Research Group - University of Alabama at Birmingham, USA. In 2010, he founded a research group to study cellular and molecular changes in autism spectrum disorders. Author or co-author of 75 scientific peer-reviewed papers and 9 book chapters. His works received more than 1400 citations so far (h-index 24). Presented 95 communications/abstracts to national and international conferences. He is serving as an editorial board member and reviewer of more than 40 international journals.
His main research interests: gene expression and molecular regulation in autism spectrum disorders; use of stem cells as therapeutic tool in autism; role of macrophage activation in autism. Other research interests: stem cells therapy for the neuronal recovery; studying of neuronal apoptosis. Role of bcl-2 family, caspases, and cell cycle regulator genes
Cardiff University,United KingdomBiography | Research Interest
Deepak Balani earned his Doctor of Dental Medicine degree from Mumbai, India in 2007. He then studied for his Masters at Cardiff University, Wales, United Kingdom. His work during his master’s thesis focused on novel diabetic rat models that allowed him to understand bone metabolism and healing which is impaired in diabetes mellitus. Immediately after his Masters, he moved to Bern, Switzerland for his PhD in Biomedical Sciences under Dr. Willy Hofstetter. His work primarily focused on studying the interplay of cytokines on the process of osteoclast differentiation and resorption in rheumatoid arthritis and ankylosing spondylitis. The publication resulting from his PhD led to the 'best basic science paper' award from the Swiss Bone and Mineral Research Society. For post-doctoral fellowship he moved to Massachusetts General Hospital and Harvard Medical School and started working under the mentor ship of Dr. Hank Kronenberg. His work primarily focuses on studying the effects of Parathyroid hormone and Anti-Sclerostin Antibody administration on mesenchymal stem cells using novel transgenic mouse models. His work recently won the prestigious 'most outstanding abstract' in the basic science category at the American Society for Bone and Mineral Research Annual Meeting in Seattle, WA. He currently works as an Instructor in Investigation at the Massachusetts General Hospital and Harvard Medical School’'.
Mesenchymal Stem Cells, Osteoblast Progenitors and Osteoporosis.
Swapan Kumar Maiti
Indian Veterinary Research Institute, IndiaBiography | Research Interest
Swapan Kumar Maiti was born in India and presently works as Principal Scientist at Indian Veterinary Research Institute. He has associated with 25 research projects and published 175 research papers, three Text-books and five manuals. He has been awarded prestigious fellowship from German Research Foundation (DFG), three times on Stem cells Biology under International Bilateral Scientist Exchange Programme of Govt. of India. He was deputed as “Visiting Professor” at the University of Leipzig, University of Köln and Technical University of Munich, Germany and also acted as Technical expert to University of Khartoum, Sudan. He has presented papers as “Speaker” in WSAVA World Congress, held in Sydney; Dublin; Geneva; Jeju and Auckland and Bangkok. He has guided eight M.V.Sc, one M. Pharm and eight Ph. D students and honored with National Awards viz. Prof A.K. Bhargava Gold Medal, Prof S.J. Angelo Memorial Award, Shri Ramlal Agrawal National Award, Indian Science Congress best paper. He also honored with “Fellow” award- from National Academy of Veterinary Sciences, Indian Society for Veterinary Surgery and Indian Society for Advancement of Canine Practice.
He is actively engaged in research on Animal cancer, Laparoscopic surgery and therapeutic application of Stem cells in animals.
Capital Medical University & Beihang University, ChinaBiography | Research Interest
Yang Zhaoyang devote herself in Neuroscience research, and the molecular mechanisms of the brain injury and SCI. In 1995 She received her Biology bachelor's degree from Shaanxi Normal University, and completed her Anatomy and histology embryology master degree at Ningxia Medical University in 2003. In 1995, Dr. Yang joined the Department of Anatomy and histology embryology at Ningxia Medical University, and in 2005 she served for the Department of Neurobiology at Capital medical University. She received her Ph. D in Neural Tissue Engineering from the Beihang University in 2010 ,with a joint appointment in Neurobiology at Capital medical University. She received honours and awards from Beijing Excellent Doctoral Dissertation and The 100th excellent doctor degree dissertation in China.
Yang laboratory research is on the application of tissue engineering to repair the injury of nervous system. Specifically her work focuses on Use a new biomaterial to control the bioactive molecules and growth factor release in the injured region. Her laboratory is also interested in how enable functional recovery after spinal cord injury. Her long term research goal is to establish this research inche within the fields of the reconstruct of the neural circuits. Over the last 16 years, she and her colleagues have studied the cellular and molecular injury mechanism underlying various CNS injury including traumatic brain and spinal cord injury. She and her colleagues have investigated the Functional hyaluronate collagen scaffolds induce NSCs differentiation into functional neurons in repairing the traumatic brain injury. She and her colleague are using the novel biological materials to promote repairative process and functional recovery after brain and SCI.
Meghnad G Joshi
D Y Patil University, IndiaBiography | Research Interest
Meghnad G Joshi did Ph.D. from department of Zoology, Shivaji University, Kolhapur, India in 2006. He Joined Karolinska Institute, Sweden as Postdoctoral fellow in 2007-2008 and worked for Sahlgrenska University Hospital, Department of transplantation surgery, Göteborg, Sweden from 2008-2010. In 2009, he was awarded with TTS New Key Opinion leader, Sweden. He has been appointed as a visiting Assistant professor by Kansas medical Center, USA since 2010 till 2012. Since 2012, he is working as Associate Professor and Head, Department of Stem Cells & Regenerative Medicine, D.Y.Patil University, Kolhapur. He is CMD of stem Plus Cryopreservation Pvt. Ltd a DCGI/FDA approved cord blood bank in Sangli, Maharashtra, India. He has published more than 25 papers and 3 patent applications in the field of regenerative medicine.
Hepatocyte (Adult and Fetal), Mesenchymal, Endothelial and Epithelial stem cell isolation, Serum free/xeno free stem cell culture, Hepatocyte transplantation, Tissue Engineering, PRP growth factors,Tissue specific growth factors isolation, Clinical stem cell transplant, Cancer biomarker studies.
Tabriz University of Medical Sciences, IranBiography | Research Interest
Rahbarghazi R is a faculty staff member of Tabriz University of Medical Sciences (Iran) who has been researching and teaching professionally in the field of stem cell biology and angiogenic signaling since 2015. Areas of interest include stem cell and endothelial cell interaction, angiogenic properties of stem cells (via juxtacrine or paracrine manner), angiogenesis signaling, stem cell-based interventions for therapeutic angiogenesis and regenerative medicine. He has a PhD in Clinical Pathology (2012) from the University of Tehran. He is currently training PhD students in Applied Cell Sciences and Stem Cell Biology.
His research is focused on the study of angiogenesis signaling and underlying mechanisms, especially the pro and anti-angiogenic properties of Mesenchymal Stem Cells (MSCs), in different conditions. Over the years, there has been much controversy over the fundamental biology, kinetics, and therapeutic application of MSCs on different kinds of pathological conditions - especially angiogenesis-dependent illnesses. Equivocal research paradigms or inconsistent results have - to some extent - contributed to the ambiguity or uncertainty over the behavior of MSCs in cell-based therapies. Our aim is to scrutinize the cellular and molecular pathways governing MSC to mediate angiogenesis process. My main object is to address the angiogenic factors through dynamic interaction of MSC-EC (endothelial cells) in a context-dependent manner in different physiopathological conditions.
Welcome to the Online Submission for Journal of Stem Cells open Access
Vol  : Issue  – Opinion Article
University of Maryland, USA
Published on 13 March, 2017
Vol  : Issue  – Research Article
Title: An Analysis of the Rejuvenative Effect of Mesenchymal Stem Cells on Aged Skin: Comparative Evaluation of Two Types; Bone Marrow-Derived and Adipose-Derived Stem Cells
University, Cairo, Egypt
Published on 14 March, 2017
Vol  : Issue  – Short Communication
Title: BACKGROUND (THE CHAOS): An Attempt towards Naming and Family Naming of Cancer Stem Cells and their Descendants.
Kumar Mallik M
Mubarak Al Kabeer Hospital, Kuwait
Published on March 21, 2017
Vol  : Issue  – Short Communication
Title: “Destined to Die”, Neural Stem and Progenitor Cells as Possible Seedbeds for Cancer: A Hypothesis and Theoretical Model 1
Kumar Mallik M
Mubarak Al Kabeer Hospital, Kuwait
Published on March 21, 2017
Vol  : Issue  – Case Report
Title: Cyclosporine Induced Posterior Reversible Encephalopathy Syndrome Post-Allogeneic Stem Cell Transplantation with Review of Literature
Cancer Institute [WIA], India
Published on March 27, 2017
The process of publication of Online Journals is complicated in the sense that it includes a number of steps. It includes editing, proofreading, quality check, web maintenance, plagiarism check and much more. The tasks included in the process of submission and publishing of the journals includes some costs and that is why the processing fees are required.
Through Scientific Synergy Open Access Journals,
- Authors can not only publish their content, but also can be sure that the quality of the journals and manuscripts are met and they are not plagiarized.
- Author work is fully reviewed, free to access for other members and are stored for lifetime in the ScientificSynergy Open Access Journals part of website. They can be accessed from any part of the world.
- Articles are provided with DOI No towards easy and proper citations.
- Articles are easily viewed in different formats as per the Author’s convenience.
* Article Processing Charges will be applicable only on the final acceptance of the article, but not on Initial Submission.
The Processing Fee (described below) paid by Author/ institution/ research funder for the articles also covers the amount to be raised for funding the Awards and Financial Support for the researchers.
If for some reasons, the Authors cannot pay the processing fee, they can submit applications for scholarships and waiver on publication fee and conferences.
Particulars regarding payment of the Processing Fee are based on the type of the manuscripts presented below
|Country||Letter to Editor (LTE)||Opinion (OP)||Short Communication (SC)||Mini Review (MRW)||Review (RW)||Case Report (CR)||Research (RA)|
|High Income||$ 359||$ 499||$ 499||$ 649||$ 849||$ 799||$ 989|
|Middle Income||$ 249||$ 399||$ 399||$ 549||$ 699||$ 649||$ 789|
|Low Income||$ 219||$ 299||$ 299||$ 399||$ 549||$ 499||$ 589|
Note: The Processing fee for the Countries has been categorized according to the current status provided in World Bank Economic status.